1.Date of occurrence of the event: 2022/10/25
2.Company name: OBI Pharma Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): Head office
4.Reciprocal shareholding ratios: Not applicable
5.Cause of occurrence:
(1)The Annual Shareholders’ Meeting of the Company resolved the issuance of restricted stock awards of a total of 500,000 common shares, each with a par value of NT$10, for a total amount of NT$5,000,000 on 2022/6/27. The issuance of restricted stock awards was approved by the Financial Supervisory Commission on 2022/7/12, approval letter No. 1110348619.
(2)The company’s Board of Directors resolved employees granted for the first issuance of restricted stock awards on 2022/8/8. The total shares issued are 160,000 shares and the Chairman was authorized to decide the record date of issuance. The record date of issuance will be 2022/10/25.
6.Countermeasures: Not applicable
7.Any other matters that need to be specified: None